Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer

Mark Garzotto, Anne Myrthue, Celestia S. Higano, Tomasz M. Beer

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences